Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 23.55
-0.37 (-1.55%)
May 20, 2026, 11:25 AM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 21.13 billion as of May 19, 2026. Its market cap has increased by 86.15% in one year.
Market Cap
21.13B
Enterprise Value
22.99B
Revenue
955.53M
Ranking
n/a
PE Ratio
233.88
Stock Price
23.55
Market Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 21.13B, an increase of 621.06%. That is a compound annual growth rate of 13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 21.13B | 33.63% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Huahai Pharmaceutical | 24.11B |
| Dizal (Jiangsu) Pharmaceutical | 23.64B |
| Walvax Biotechnology | 22.36B |
| Kangmei Pharmaceutical | 22.26B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 21.90B |
| Tasly Pharmaceutical Group | 21.47B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 20.89B |
| Jilin Aodong Pharmaceutical Group | 20.83B |